XSUS:CA:TSX-iShares ESG MSCI USA Index (CAD)

ETF | US Equity |

Last Closing

CAD 40.23

Change

0.00 (0.00)%

Market Cap

CAD 0.47B

Volume

2.40K

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-08-31 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.87 (+0.64%)

CAD 16.35B
ZSP:CA BMO S&P 500

+0.59 (+0.71%)

CAD 15.56B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.33 (+0.56%)

CAD 10.26B
VUN:CA Vanguard US Total Market

+0.84 (+0.83%)

CAD 9.10B
XUS:CA iShares Core S&P 500 Index ETF

+0.30 (+0.64%)

CAD 7.07B
HXS:CA Global X S&P 500 Corporate Cla..

+0.54 (+0.70%)

CAD 3.88B
VSP:CA Vanguard S&P 500 CAD hedged

+0.53 (+0.58%)

CAD 3.35B
QUU:CA Mackenzie US Large Cap Equity ..

+1.34 (+0.61%)

CAD 3.06B
XUU:CA iShares Core S&P US Total Mark..

+0.52 (+0.93%)

CAD 2.96B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.30 (+0.61%)

CAD 2.85B

ETFs Containing XSUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 20.38% 80% B- 78% C+
Dividend Return N/A N/A N/A N/A N/A
Total Return 20.38% 80% B- 78% C+
Trailing 12 Months  
Capital Gain 22.88% 70% C- 74% C
Dividend Return N/A N/A N/A N/A N/A
Total Return 22.88% 70% C- 74% C
Trailing 5 Years  
Capital Gain 99.26% 91% A- 82% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 99.26% 91% A- 82% B
Average Annual (5 Year Horizon)  
Capital Gain 13.62% N/A N/A 80% B-
Dividend Return 14.41% N/A N/A 78% C+
Total Return 0.78% N/A N/A 33% F
Risk Return Profile  
Volatility (Standard Deviation) 14.37% N/A N/A 56% F
Risk Adjusted Return 100.28% N/A N/A 97% N/A
Market Capitalization 0.47B 54% F 58% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.